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Abstract:  This study estimates the avoidable and unavoidable costs of alcohol-related, 
liver cirrhosis inpatient care, controlling for the lag structure and period of decline in 
disease risk. Lag structures with different lengths are applied to the exposure to risk from 
alcohol consumption, which allows for differentiation between avoidable and unavoidable 
cases due to prior consumption. A lag length of 20 (men) and 23 (women) years (expected 
remaining life years) gives a total cost of 592 million SEK. Given alcohol consumption is 
reduced to zero, 72% of cost could potentially be avoided. It is important to account for the 
length and structure of the risk decline following a consumption change as this 
substantially affects the estimates.  
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1. Introduction  
A number of studies have estimated the total cost of alcohol (COA) consumption [1-3]. Although 
the results of these studies are interesting, their relevance for policy is limited as they neither assist 
with resource allocation decisions nor accurately specify areas that should be targeted by interventions. 
The main advantage of COA studies is rather to serve as a starting point for further studies, by defining 
and valuing the current costs and benefits connected to current and previous alcohol consumption [4]. 
Economic evaluations, however, are needed to choose between potential alcohol interventions, and this 
requires detailed knowledge about the potential future benefits from reductions in alcohol 
consumption. Thus, one problem with COA studies is that they do not differentiate between costs 
which can be avoided and those which are unavoidable at a particular point in time. For that reason, 
avoidable costs, costs that can be avoided given a reduction in current and future risky alcohol use, are 
of primary interest as it is through this concept that more accurate prioritisation and ranking between 
policies/interventions may be based.  
As compared with traditional COA studies, the counterfactual scenario needs to be changed when 
estimating the avoidable cost. COA studies generally use a counterfactual scenario of a society without 
the adverse effects of current or previous alcohol consumption. A more realistic scenario is to compare 
the expected future cost of alcohol consumption, with a society where alcohol consumption is reduced 
at a certain point in time. This may result from a hypothetical or existing intervention with known 
effect. Following the definition in international guidelines, the total cost of alcohol is made up of two 
parts, the avoidable and unavoidable cost  [4]. The unavoidable part consists  of already existing 
alcohol-related diseases and new cases due to prior consumption,  plus  cases due to continued 
(irreducible) consumption (consumption which cannot be reduced further regardless of the degree and 
number of interventions implemented, given current level of knowledge). The avoidable part is thus 
those cases that are amenable by interventions and behaviour changes [4], which can be difficult to 
define for a particular population, at a given point in time, given the large range of interventions or 
possible combinations. We point out that it is also important to identify the future cost due to prior 
consumption separately from continued irreducible consumption as this will give an indication with 
regards to the potential future cost saving of developing new, more effective, interventions. The point 
being that what is continued irreducible consumption today not necessarily remains so tomorrow. Thus, 
the current study makes this distinction. In order to make the difference of the current definition and 
the definition in the international guidelines clear, we refer to the current as unavoidable cost due to 
prior consumption. 
The estimation of avoidable costs is  normally justified by its contribution to: (1) prioritising 
expenditure of public funds; (2) facilitating analysis of intervention programs as well as the design of 
such programs; (3) identifying information gaps both in research and data collection; and (4) improving 
the analysis of the cost-effectiveness of policies and interventions [4]. A more general and maybe more 
important  justification  is that estimation of avoidable costs would probably foster research and 
development in areas where potential cost savings are significant [5]. This latter general justification 
point out the importance of what was discussed above, that unavoidable cost due to prior consumption 
is differentiated from unavoidable cost due to continued irreducible consumption.  
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Estimating the avoidable cost of alcohol consumption is a new area of research. Following the 
publication of guidelines for estimating the  social cost of substance abuse by the World  Health 
Organisation (WHO)  in 2003 [6], Health Canada initiated a workshop in 2005 with the aim of 
producing theoretical guidelines for estimating  the  avoidable cost of substance abuse. As well as 
working  towards  the  development of sound methodologies and approaches, the intention was  to 
encourage and provide guidance for pilot studies in this area. Although the resulting guidelines build 
on the most recent knowledge in all relevant areas such as epidemiology and criminology, it is 
expected that empirical work will encounter a multitude of challenges which will develop the 
guidelines [4]. To date, three robust attempts have been made to estimate the avoidable costs of alcohol 
consumption [7-9],  two  of which are a direct result of the theoretical guidelines using the   
same definitions [7,8].  
A Canadian study estimated  the avoidable health care, crime and indirect costs following six 
potential interventions in the alcohol field  while  Collins and Lapsley estimate the avoidable   
alcohol-related cost following seven potential interventions for Australia [7,8]. Although both studies 
use some potential interventions to help determine the irreducible consumption and thus avoidable 
cost, other approaches to define the irreducible consumption are also tested. All effects from reduction 
in alcohol consumption are considered immediate in both studies, i.e., no time characteristics of risk 
decline were accounted for in the estimations, due to data limitations. This is dealt with to some extent 
in a study from the UK, which investigates the effect on alcohol-related harm from different   
alcohol-related interventions [9]. The authors assume a lag length of 10 years before the full health 
effect of a consumption change is manifested. It is further assumed that the lag structure is linear, i.e., 
that each year has an equal proportion of risk decline. In general, the report includes harm related to 
health, crime and employment and a total of 53 different scenarios were estimated showing avoidable 
effects and costs [9].  
Thus, a major obstacle to allowing for temporal characteristics in prior research has been a lack of 
data, forcing the issue to be overlooked or handled with somewhat subjective assumptions. The current 
study develops a method for handling the time characteristic of risk decline following a consumption 
change based on population information available for liver cirrhosis. In order to illustrate the method in 
the current study we also estimate the unavoidable cost due to prior consumption. 
Aim 
The aim is to extend and apply methods to estimate the societal avoidable and unavoidable cost of 
inpatient care due to liver cirrhosis, accounting for the time characteristics of risk decline. We use a 
counterfactual scenario where alcohol vanishes overnight, i.e., where effects of prior consumption still 
lingers but where present and future consumption is abolished, in order to estimate the unavoidable 
cost due to prior consumption as discussed above. The results for men and women are presented 
separately, but the calculations for women are shown in more detail in the text while the detailed 
results for men are found in the appendix. The focus is on liver cirrhosis as it has been shown to have a 
very strong link to alcohol consumption and thus alcohol-related harm [10]. A crucial assumption is 
that the age and gender characteristics of the population and the distribution of alcohol consumption in 
the actual scenario are  constant,  i.e.,  children who grow up start consuming according to the Int. J. Environ. Res. Public Health 2010, 7                 
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distribution in year zero. In the counterfactual scenario, children who grow up do not start consuming 
alcohol. Alternatively, the population at year zero could be fixed and followed until death. However, 
the results of such a study would not be comparable with the COA literature. The base of this study is 
the recent Swedish COA study [11,12] and this should be seen as a step towards extending methods to 
allow for the future estimation of the avoidable cost. 
The Swedish COA study estimated a total net cost of alcohol consumption in 2002 of 20.3 billion 
Swedish kronor (SEK). The cost of inpatient liver cirrhosis care was estimated to be 37 million (SEK) 
out of which women’s consumption stood for 12 million (SEK). A total of 328 (677) liver cirrhosis 
cases (ICD-10 codes K70 & K74) were attributed to alcohol consumption for women (men) with a unit 
cost of 36,796.75 SEK. That is, in the counterfactual scenario of no adverse effects of alcohol 
consumption 328 cases would have been averted for women, as shown in Table 1 [12].  
Table 1. Alcohol attributable liver cirrhosis cases for women, inpatient care. 
Age  Cases  PAF* 
Cases due 
to alcohol 
0–14  9  0  0 
15–17  2  0.46  1 
18–29  9  0.52  5 
30–49  163  0.47  76 
50–64  359  0.44  157 
65–79  312  0.26  80 
80+  48  0.20  10 
Total:  902    328 
Columns and calculations may not sum due to rounding. 
* Population attributable fraction 
2. Method 
The total cost estimated in the Swedish COA study is a yearly moment-in-time assessment of the 
cost. However, the increased risk of disease is expected to decline gradually over time following a 
reduction of  alcohol consumption,  i.e.,  the temporal path  of decline in disease risk needs  to be 
accounted for when estimating the  avoidable cost. This is challenging, especially as there is a 
considerable lack of research on the  time  path  of disease risks. To the authors’ knowledge, no 
individual level study exists that investigates how the risk of liver cirrhosis changes over time 
following a change in alcohol consumption.  
However, the lag structure of population consumption on liver cirrhosis mortality has been 
investigated  somewhat  in aggregated time series analyses [13]. It is generally found that the lag 
structure is surprisingly short and that changes in alcohol consumption have an immediate, substantial 
effect on mortality rates [13-15]. Additional lags affect the mortality rates at a decreasing rate, which is 
surprising as alcoholic liver cirrhosis takes several years to develop [13]. Int. J. Environ. Res. Public Health 2010, 7                 
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2.1. Lag Structure 
This study employs the lag structure modelled by Norström [13] which includes both the short- and 
long-term effects of changes in alcohol consumption, originally suggested by Skog [16]: 
i i
i p p w 2 1 ) 1 ( λ λ − + =      (1)  
where  wi  is the weight of consumption  in  year  i,  λ1  and  λ2  are the geometrically declining lag 
parameters for the short- and the long-term effects respectively and p is the relative importance of the 
short term effect [13]. In the same study, using Swedish data, Norström concludes that appropriate 
parameter values are 0.50 for λ1, 0.93 for λ2, and 0.80 for p, which were close to the values obtained in 
an earlier study using British and French data [16]. The short-term effect is thus considered to be 
stronger than the long-term effect, although it dies out faster. It follows that the lag weights decline at a 
decreasing rate, not reaching zero within a human lifetime. However, the weight quickly becomes 
small (below 0.1 after 9 years, below 0.05 after 19 years, and below 0.01 after 41 years) making the 
inclusion of an additional lag of diminishing importance, especially considering the need to discount 
future costs. A 3% discount rate will be used in the current study, following the Swedish   
COA study [11]. 
The UK study assumes a time period of 10 years (including the initial year, i.e., the immediate 
effect) between consumption change and the full effect [9]. The assumption is based on the time period 
for developing a disease, averaged over all alcohol-related chronic diseases. A 10 year lag period has 
also been used by Ramstedt when estimating the effect of changes in per capita consumption on liver 
cirrhosis mortality [17]. Following these prior studies, the current paper also uses a 10 year lag period, 
in addition to an “average expected remaining life years” period. This will establish the sensitivity of 
the results with regard to the length of the period for disease risk decline. The appropriate length of the 
lag period will be dependent on the lag structure and the chosen discount rate and is therefore expected 
to be disease specific. The weights for the 10 year lag period are shown in Table 2.  
Table 2. Weights of the lag structure. 
Year  Weight 
Proportion per 
lag 
Cumulative 
proportion 
0  1.00  0.33  0.33 
1  0.59  0.19  0.52 
2  0.37  0.12  0.64 
3  0.26  0.08  0.72 
4  0.20  0.06  0.79 
5  0.16  0.05  0.84 
6  0.14  0.05  0.89 
7  0.13  0.04  0.93 
8  0.12  0.04  0.97 
9  0.11  0.03  1.00 
 
The weights are summed (=3.073) and a proportion for each year is calculated based on the ten year 
time period. That is, 33% of the total reduction in liver cirrhosis following abstention occurs Int. J. Environ. Res. Public Health 2010, 7                 
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immediately (1/3.073) while 3% occurs in the tenth year (0.11/3.073). After ten years the full effect of 
the risk decline are manifested, following the assumption above.  
As the lag structure is based on aggregate consumption, it is not known to what extent these weights 
are different between consumption groups. With such data,  it would have been possible to have 
different weights and even different time periods depending on level of consumption. Without such 
data, an additional assumption is required stating that the risk decline following consumption change is 
proportionally the same between individuals, independent of level of original consumption. Regarding 
liver cirrhosis, this assumption is of less concern as the disease normally is considered to develop from 
long-term consumption [13] and increased risk of disease is based on level of consumption [17 and 
referred literature] and not from periodic binge drinking.  
2.2. Exposure Based Lag Structure 
The lag structure should be modelled directly on the relative risk of disease as this will allow the 
estimation of new cases over the time period. The results of the alternative approach, i.e., modelling 
the temporal characteristics on the outcomes, should be interpreted as the distribution of the length of 
treatment, i.e., a focus on palliative and curative services [5]. That is, the study needs to be exposure 
based rather than outcome based [5]. The advantage of focusing on exposure is that it allows for 
differentiation between avoided and delayed effects, which is theoretically more appropriate for 
avoidable cost calculations. The relative risk (RR) is simply:  
RR
P
P
osed un
osed =
exp
exp    (2)  
where P is the probability of an event for exposed and unexposed respectively. The probability of an 
event for those exposed comprises two components, the probability of an event for those unexposed 
(baseline) and the change in risk following exposure: 
osed osed un P P P exp exp = ∆ +    (3)  
By inserting (3) in (2) and rearranging, we get: 
P P P RR osed un osed un ∆ = − exp exp ) * (   (4)  
If we now assume a change in the probability of an event for those exposed, which will affect the 
relative risk, this can be modelled as: 
new
osed un
osed un RR
P
P x P
=
∆ + +
exp
exp ) 1 (
  (5)  
By substituting (4) into (5) and simplifying, the following is given: 
new RR x x RR = − + ) 1 (   (6)  
The last formula thus gives the new relative risk based on a change in the probability of an event in 
the exposed group when only the original relative risk and the actual change in probability is known. 
Applying equation (6), where x is the negative cumulative proportion of weights in Table 2, in the case 
of liver cirrhosis gives the relative risks after abstention (Table 3). Int. J. Environ. Res. Public Health 2010, 7                 
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Table 3. Relative risk of liver cirrhosis for women following abstention with a 10 year  
lag period. 
Year*  Abstinence  Low  Hazardous  Harmful 
−1  1.00  1.30  9.50  13.00 
0  1.00  1.20  6.73  9.09 
1  1.00  1.15  5.11  6.81 
2  1.00  1.11  4.08  5.35 
3  1.00  1.08  3.36  4.33 
4  1.00  1.06  2.81  3.55 
5  1.00  1.05  2.35  2.91 
6  1.00  1.03  1.96  2.36 
7  1.00  1.02  1.61  1.86 
8  1.00  1.01  1.29  1.41 
9  1.00  1.00  1.00  1.00 
* Year−1 is the current situation while year 0 is the immediate effect of abstention 
in the counterfactual scenario. The same drinking categories are used as in the 
Global Burden of Disease study [18]. Abstinence (no alcohol within last year), low 
consumption (women 0–19.99  grams (gr)  pure alcohol per day, men 0–39.99), 
hazardous consumption (women 20–39.99, men 40–59.99), and harmful 
consumption (women 40+, men 60+) 
 
It is now possible to calculate the number of new cases following abstention. The following formula 
is used for the calculation of the alcohol attributable fraction (AAF): 
∑
∑
=
=
− +
−
=
0
1
) 1 ( * 1
) 1 ( *
i i i
i i i
RR P
RR P
AAF   (7)  
where i denotes the drinking categories (see Table 3), P is the prevalence rate and RR is the relative 
risk of the i:th category. As the distribution of alcohol consumption differs over age, different AAFs 
are calculated for seven different age groups (Table 1). Given the fact that the number of alcohol 
related cases are reduced each year in the counterfactual scenario, it follows that the total number of 
liver cirrhosis cases (alcohol and non-alcohol related cases) are also reduced each year. That is, the 
number of cases to which the AAF is applied is adjusted for each consecutive year according to the 
number of alcohol-related cases avoided in the year before. For example, there are originally 902 
female cases of liver cirrhosis in Sweden in 2002 (Table 1), following abstention 74 alcohol-related 
cases (out of 328) are avoided in year 0 leaving 828 cases in the beginning of year 1.  
3. Results  
In Table 4 are the estimated cases and costs of liver cirrhosis for women with a 10 year long lag 
period shown. The inpatient health care costs for alcohol attributable liver cirrhosis comprises two 
parts, one unavoidable part due to prior alcohol consumption, and one avoidable part that would 
disappear if alcohol vanished overnight in year 0. Over the full ten year period, the unavoidable part 
sums to 30 million SEK while the avoidable part sums to 76 million SEK, giving a total cost of 
alcohol-related liver cirrhosis due to current consumption pattern of 106 million SEK, i.e., potentially Int. J. Environ. Res. Public Health 2010, 7                 
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72% of the total cost of alcohol-related liver cirrhosis is avoidable over a 10 year period for women. In 
the Swedish COA study, the cost for year 0 was estimated to be 12 million SEK. Table 4 shows that 
this cost is 23% avoidable, a proportion that is increased for each consecutive year, culminating at 
100% avoidable by the tenth year. For each additional year,  starting with year 11, 328 cases are 
avoidable in the counterfactual scenario, although the costs are more heavily discounted. This raises 
the question of when to stop counting. In the current situation, it makes some sense to stop after  
10 years as, given the assumptions, the theoretical minimum risk is reached (the lowest possible risk). 
However, if the 10 year period assumption is relaxed, the theoretical minimum risk will be reached at a 
different time point. Table 5 shows the number of avoidable and unavoidable cases and costs for both 
women and men. The avoidable proportion is slightly lower for men (71%). 
Table 4. Avoidable and unavoidable liver cirrhosis cases and costs for women, 10 years. 
Year  Cases 
Cases 
avoided* 
Unavoidable 
cost, undisc. 
Avoidable cost, 
undisc. 
Unavoidable 
cost, disc. 
Avoidable 
cost, disc. 
−1  328  0  12,071,582  0  12,071,582  0 
0  254  74  9,352,724  2,718,858  9,352,724  2,718,858 
1  183  146  6,716,043  5,355,540  6,520,430  5,199,553 
2  132  196  4,848,215  7,223,368  4,569,907  6,808,717 
3  98  230  3,594,030  8,477,552  3,289,047  7,758,161 
4  73  255  2,698,800  9,372,783  2,397,848  8,327,596 
5  54  274  1,998,737  10,072,846  1,724,128  8,688,925 
6  38  290  1,410,098  10,661,484  1,180,935  8,928,825 
7  24  304  892,527  11,179,055  725,706  9,089,595 
8  12  316  426,045  11,645,538  336,324  9,193,095 
9  0  328  0  12,071,582  0  9,251,863 
Total  868  2,413  31,937,218  88,778,606  30,097,050  75,965,189 
* Compared to the original situation, i.e., year −1. 
 
Table 5. Avoidable and unavoidable liver cirrhosis cases and discounted costs, 10 years. 
 
Cases 
unavoidable 
Cases 
avoidable 
Costs 
unavoidable 
Costs 
avoidable 
Women  868  2,413  30,097,050  75,965,189 
Men  1,815  4,951  62,953,983  155,782,017 
Total  2,683  7,363  93,051,032  231,747,206 
 
As noted above, Meier et al. is the only existing study that controls for the time characteristic of risk 
decline. This is done by assuming a 10 year lag period with a linear risk decline [9]. To allow for 
comparison, the results from Table 5 are reproduced below (Table 6) using the same assumption. It is 
shown that failure to account for the stronger short-term effect, compared to the long-term effect, will 
underestimate the amount of cost that could be avoided. It is even the case that the avoidable cost is 
lower than the unavoidable cost, due to the fact that avoidable costs are more heavily discounted as this 
is predominantly a late effect. Int. J. Environ. Res. Public Health 2010, 7                 
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Table 6. Avoidable and unavoidable liver cirrhosis cases and discounted costs, 10 years 
and linear risk decline. 
 
Cases 
unavoidable 
Cases 
avoidable 
Costs 
unavoidable 
Costs avoidable 
Women  1,570  1,710  53,479,839  52,582,399 
Men  3,267  3,499  111,241,973  107,494,027 
Total  4,837  5,209  164,721,812  160,076,426 
3.1. Lifelong Lag 
The 10 year lag period applied above was used based on assumptions in earlier studies. However, 
the lag structure attained from Norström [13] implies that the increased risk of developing liver 
cirrhosis due to alcohol consumption compared to abstention never really disappears. Thus, alcohol 
consumers can expect to have an increased risk of disease until death, even if they become abstainers. 
This section will therefore calculate the increased risk and associated costs for the expected remaining 
life years. On average liver cirrhosis patients in Swedish inpatient care were 60 years of age (the same 
for women and men) in 2002. The corresponding expected remaining life years for these patients were 
24 and 21 years for women and men respectively [19].  
The associated costs are, as expected, higher when the lag period is increased, given that counting 
stops when the theoretical minimum is reached. The total cost for the lifelong lag sums to 211 million 
SEK, see Table 7, i.e., almost twice the cost of the 10 year lag. However, the proportion of the costs 
that theoretically could be avoided by complete societal abstention is only marginally affected, 
increasing by 1 percentage point to 73%. This is to some extent a result of discounting, putting less 
weight on later years. The corresponding cost for men is 381 million SEK out of which 72% are 
avoidable over the next 20 years, see Table 8. 
Table 7. Avoidable and unavoidable liver cirrhosis cases and costs for women, expected 
remaining life years. 
Year  Cases 
Cases, 
avoided* 
Unavoidable, 
cost, undisc. 
Avoidable, 
cost, undisc. 
Unavoidable, 
cost, disc. 
Avoidable 
cost, disc. 
−1  328  0  12,071,582  0  12,071,582  0 
0  272  56  10,025,817  2,045,766  10,025,817  2,045,766 
1  219  109  8,043,836  4,027,746  7,809,550  3,910,433 
2  179  149  6,601,647  5,469,935  6,222,686  5,155,939 
3  152  176  5,604,762  6,466,820  5,129,152  5,918,056 
4  133  195  4,884,660  7,186,922  4,339,957  6,385,487 
5  118  211  4,323,788  7,747,795  3,729,737  6,683,316 
6  105  223  3,856,319  8,215,264  3,229,606  6,880,154 
7  94  234  3,448,125  8,623,457  2,803,641  7,011,660 
8  84  244  3,081,670  8,989,912  2,432,699  7,096,720 
9  75  253  2,747,595  9,323,987  2,105,803  7,146,060 
10  66  262  2,440,510  9,631,072  1,815,969  7,166,422 
11  59  269  2,156,983  9,914,600  1,558,250  7,162,518 
12  51  277  1,894,576  10,177,007  1,328,817  7,137,948 Int. J. Environ. Res. Public Health 2010, 7                 
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Table 7. Cont. 
13  45  283  1,651,391  10,420,191  1,124,517  7,095,643 
14  39  289  1,425,848  10,645,735  942,653  7,038,085 
15  33  295  1,216,566  10,855,016  780,868  6,967,422 
16  28  300  1,022,314  11,049,268  637,072  6,885,539 
17  23  305  841,973  11,229,609  509,408  6,794,098 
18  18  310  674,519  11,397,064  396,209  6,694,574 
19  14  314  519,009  11,552,574  295,983  6,588,271 
20  10  318  374,575  11,697,008  207,393  6,476,350 
21  7  322  240,414  11,831,168  129,234  6,359,836 
22  3  325  115,785  11,955,798  60,427  6,239,641 
23  0  328  0  12,071,582  0  6,116,571 
Total  1,826  6,047  67,192,682  222,525,297  57,615,449  152,956,508 
* Compared to the original situation, i.e., year−1. 
Table 8. Avoidable and unavoidable liver cirrhosis cases and discounted costs, expected 
remaining life years. 
  Cases, 
unavoidable 
Cases, 
avoidable 
Costs, 
unavoidable 
Costs, 
avoidable 
Women  1,826  6,047  57,615,449  152,956,508 
Men  3,305  10,226  106,894,811  274,601,315 
Total  5,131  16,274  164,510,260  427,557,824 
3.2. Sensitivity Analysis 
One sensitivity analysis was conducted regarding the parameter values in equation 1. Instead of the 
values estimated by Norström [13] the values estimated from British and French data by Skog [16] 
were used (0.60 for λ1, 0.95 for λ2, and 0.85 for p). Thus, the short term effect is stronger and declines 
less rapidly. However, this is countered by an increase in the long-term effect. The results show that 
using the values from the Skog study would increase the number  of cases and costs that are 
unavoidable due to prior consumption, although marginally, see Table 9.  
Table 9.  Sensitivity analysis of avoidable and unavoidable liver cirrhosis cases and 
discounted costs, 10 years for women. 
 
Cases, 
unavoidable 
Cases, 
avoidable 
Costs, 
unavoidable 
Costs, 
avoidable 
Baseline  868  2,413  30,097,050  75,965,189 
Skog, 1984  871  2,410  30,267,354  75,794,884 
 
4. Discussion 
Even if alcohol consumption magically disappeared overnight, Swedish society would still suffer 
the cost of alcohol-related liver cirrhosis in the magnitude of 165 million SEK, based on the remaining 
life years lag structure. However, a cost in the magnitude of 428 million would have been avoided, 
showing the maximum theoretical gain from alcohol interventions with regard to liver cirrhosis.  Int. J. Environ. Res. Public Health 2010, 7                 
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Prior studies have used a 10 year long lag structure which, as expected, results in substantially lower 
costs. However, in order for the estimates to be comparable, the cost in the 10 year lag period should 
be extrapolated over expected remaining life years where the full effect of the risk decline is added to 
each additional year. As noted above, the lag structure obtained declines at a decreasing rate. It thus 
appears that the most appropriate length is to use the expected remaining life years as the increased risk 
due to alcohol consumption does not reach zero within a normal human life span. It should be noted 
that this is in regard to how long the unavoidable cost due to prior consumption needs to be considered 
but not how long the benefits from reducing alcohol consumption should be considered as the 
beneficial effects will continue after the adverse effects of prior consumption   
has disappeared. 
The Swedish COA study estimated that the cost of alcohol-related liver cirrhosis for inpatient care 
in 2002 amounted to 37 million SEK. This is the cost that would be avoided in one year if the full 
effect of a consumption change occurred immediately. Although the current study shows that the 
immediate effect is substantial, assuming that the full sum could be saved in 2002 would be vastly 
misleading. The immediate cost saving would only be 17% of the total cost, as estimated in the   
current study.  
The lag structure employed in the current paper indicates a higher relative importance of the   
short-term effect. The proportionally higher avoidable, compared  with unavoidable, cost is largely 
driven by this. The comparison of this study’s result with a linear risk decline,  as used in prior   
research [9], shows that the difference is substantial. It is expected that failure to account for the strong 
short term effect could bias cost-effectiveness ratios in future economic evaluations. 
One limitation in the Canadian and Australian avoidable cost studies, which is also pointed out by 
the respective authors, is that the lag structure cannot be estimated due to data limitations. The full 
effect of risk decline following a change in consumption could thus mistakenly be interpreted to be 
manifested immediately, i.e., in year zero [7,8]. This problem is discussed in the reports, and the 
Canadian study even goes so far as to conduct a literature review regarding the current knowledge of 
the lag structure for different alcohol-related diseases  [7].  In the case of the current hypothetical 
intervention, this interpretation of an immediate effect would make the estimate of avoidable cost in 
year zero equal to the total cost of alcohol consumption, which certainly is not the case. The UK study 
takes something of a middle ground, estimating the avoidable cost of existing interventions although 
applying a method that makes it easy to differentiate between avoidable and total cost even if the 
current hypothetical intervention was used [9].  
The use of economic evaluations is much less developed in the alcohol field compared with many 
other areas of health economics. This is due to the fact that the impact of alcohol is complex and  
multi-dimensional. It affects for example crime, productivity, health and quality of life which make 
evaluations difficult to carry out. The result of this is a limited knowledge about the cost-effectiveness 
of interventions and policies targeting alcohol-related harm. While estimating the theoretically 
avoidable cost of alcohol consumption is of limited importance on its own, using this information in 
connection with economic evaluations of interventions will provide important direction for   
policy-makers and society. Estimating the theoretically avoidable cost will facilitate future economic 
evaluations. It is thus important that the current study is considered in connection with future economic Int. J. Environ. Res. Public Health 2010, 7                 
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evaluations in the alcohol field, thereby increasing the practical importance of research on the cost of 
alcohol. 
One limitation of the current study is that it has not been possible to differentiate between new and 
existing cases in year 2002, i.e., the cases developed prior to the hypothetical disappearance of alcohol 
consumption need to be identified in order to give a complete picture of the avoidable and unavoidable 
cost, due to prior consumption. Liver cirrhosis patients who stop consuming alcohol are treated for 
about 3–5 years (shorter for those who continue to drink). However, it is not currently clear whether 
they are registered as inpatient cases beyond the initial hospitalisation spell. The incidence-prevalence 
ratio at year zero could not be studied at this time due to data limitations but should be investigated in 
future research. Such a study, however, will have to deal with the difficulty of not only separating 
existing from new cases in year zero but also controlling for those patients who  do not stop   
consuming alcohol. 
Another issue that needs to be accounted for in future studies of the avoidable cost is the trend of 
alcohol consumption. If per capita consumption is rising over time after year zero, the counterfactual 
scenario will result in even larger avoidable cost, and vice versa, for a decline in consumption.  
Another type of study that is needed more desperately than any other, in order to estimate the 
avoidable cost of alcohol, is investigations of the disease-specific risk decline following reduction in 
consumption for all alcohol-related diseases. Currently this information is largely lacking. Unless this 
data  could be attained through epidemiological studies, it could potentially be studied using the 
approach in Norström [13] and Skog [16] on which the current study relies. Future developments in 
this area should also considerer the potentially different effects on risk decline following different 
length, volume and pattern of consumption. It is possible that the effect of drinking cessation on risk 
decline is dependent on how long the individual has consumed alcohol and in what manner. Besides, 
the current study has assumed the same proportional risk decline irrespective of consumption level. 
This need not be correct as it is possible that the function of risk decline is different between different 
consumption groups.  
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Appendix 
Table A1. Alcohol attributable liver cirrhosis cases for men, inpatient care. 
Age  Cases  PAF*  Cases due to alcohol 
0–14  1  0.00  0 
15–17  0  0.40  0 
18–29  4  0.60  2 
30–49  235  0.51  120 
50–64  814  0.46  371 
65–79  468  0.35  162 
80+  67  0.32  22 
Total  1 589    677 
Columns and calculations may not sum due to rounding. 
* Population attributable fraction 
Table A2. Avoidable and unavoidable liver cirrhosis cases and costs for men, 10 years. 
Year  Cases 
Cases 
avoided* 
Unavoidable 
cost, undisc. 
Avoidable 
cost, undisc. 
Unavoidable 
cost, disc. 
Avoidable 
cost, disc. 
−1  677  0  24,895,662  0  24,895,662  0 
0  532  145  19,574,946  5,320,716  19,574,946  5,320,716 
1  384  293  14,126,092  10,769,570  13,714,653  10,455,893 
2  276  400  10,168,165  14,727,498  95,84,470  13,882,079 
3  204  473  7,502,131  17,393,531  68,65,513  15,917,545 
4  153  524  5,613,419  19,282,243  4,987,450  17,132,024 
5  113  564  4,148,641  20,747,022  3,578,654  17,896,563 
6  79  597  2,923,446  21,972,216  2,448,340  18,401,385 
7  50  626  1,849,118  23,046,544  1,503,502  18,738,950 
8  24  653  882,249  24,013,413  696,456  18,956,410 
9  0  677  0  24,895,662  0  19,080,452 
Total  1,815  4,951  66,788,206  182,168,416  62,953,983  155,782,017 
* Compared to the original situation, i.e., year−1. Int. J. Environ. Res. Public Health 2010, 7                 
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Table A3. Avoidable and unavoidable liver cirrhosis cases and costs for men, expected 
remaining life years. 
Year  Cases 
Cases 
avoided* 
Unavoidable 
cost, undisc. 
Avoidable 
cost, undisc. 
Unavoidable 
cost, disc. 
Avoidable 
cost, disc. 
−1  677  0  24,895,662  0  24,895,662  0 
0  563  114  20,708,534  4,187,128  20,708,534  4,187,128 
1  447  230  16,430,169  8,465,493  15,951,620  8,218,925 
2  360  317  13,244,896  11,650,766  12,484,585  10,981,964 
3  300  377  11,036,705  13,858,957  10,100,149  12,682,909 
4  257  420  9,451,401  15,444,261  8,397,448  13,722,026 
5  224  453  8,225,541  16,670,121  7,095,424  14,379,793 
6  196  481  7,208,986  17,686,676  6,037,412  14,812,313 
7  172  505  6,323,891  18,571,771  5,141,902  15,100,549 
8  150  526  5,530,568  19,365,094  4,365,881  15,286,984 
9  131  546  4,808,045  20,087,617  3,684,966  15,395,486 
10  113  564  4,144,359  20,751,303  3,083,792  15,440,918 
11  96  581  3,531,935  21,363,728  2,551,545  15,433,611 
12  81  596  2,965,415  21,930,247  2,079,882  15,381,434 
13  66  610  2,440,635  22,455,027  1,661,954  15,290,781 
14  53  623  1,954,126  22,941,536  1,291,908  15,167,058 
15  41  636  1,502,871  23,392,791  964,636  15,014,942 
16  29  647  1,084,174  23,811,488  675,621  14,838,532 
17  19  658  695,589  24,200,073  420,843  14,641,442 
18  9  667  334,882  24,560,780  196,708  14,426,870 
19  0  677  0  24,895,662  0  14,197,648 
Total  3,305  10,226  121,622,724  376,290,521  106,894,811  274,601,315 
* Compared to the original situation, i.e., year−1. 
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